PMCK Berhad plans to raise approximately RM23.99 million through a private placement, with the bulk of the proceeds earmarked for a new robotic-assisted surgery system and upgrades to medical equipment and infrastructure at Putra Medical Centre (PMC) in Alor Setar.
The proposed exercise will involve the issuance of up to 109.06 million new ordinary shares, equivalent to 10% of PMCK’s existing issued share capital of about 1.09 billion shares.
The placement shares will be offered to independent third-party investors at an indicative issue price of 22 sen per share.
A key component of the investment is the acquisition of a robotic-assisted surgery system estimated to cost RM11 million, comprising the robotic platform, instruments, installation and training.
The system will be installed within PMC’s existing operating theatre and is expected to expand the hospital’s surgical capabilities across several specialties.
PMCK said the technology would enable PMC to offer robotic-assisted minimally invasive procedures in General Surgery, Obstetrics and Gynaecology, and Urology.
Robotic-assisted procedures can provide surgeons with greater precision when performing complex minimally invasive operations and could potentially shorten patients’ recovery periods and hospital stays.
The investment comes as robotic-assisted surgery gains wider adoption within the private healthcare industry, particularly for complex procedures where minimally invasive approaches are increasingly preferred.
PMCK said the acquisition would allow the hospital to keep pace with technological developments in private healthcare while strengthening its ability to provide more advanced surgical treatments.
Beyond enhancing patient care, the technology is also expected to support PMCK’s efforts to attract and retain a new generation of surgeons.
The company noted that younger surgeons are increasingly being trained to use robotic platforms and may prefer to practise at hospitals equipped with such systems.
Providing access to robotic-assisted surgery could therefore strengthen PMCK’s clinical talent pipeline while enhancing Putra Medical Centre’s position in the northern region’s private healthcare market.
Apart from the robotic surgery system, proceeds from the private placement will be used to upgrade PMC’s medical, surgical and diagnostic equipment, as well as hospital infrastructure and information technology systems.
The planned investments are aimed at improving the hospital’s overall clinical and operational capabilities as PMCK seeks to enhance the range and quality of healthcare services offered at its Alor Setar facility.
At the indicative placement price of 22 sen per share, the issuance of 109.06 million shares would raise gross proceeds of approximately RM23.99 million.
The proposed fundraising would provide PMCK with additional capital to undertake the investments while positioning PMC to capture demand for increasingly sophisticated private healthcare and surgical services.
